Cholecystitis Disease

BASICS

DESCRIPTION

Inflammation of the gallbladder occurring acutely or chronically, often secondary to previously asymptomatic gallstones.

  • System(s) affected: Gastrointestinal
  • Genetics: Increased prevalence in Native Americans and Caucasians, less prevalent in African Americans
  • Incidence/Prevalence in USA:
    • Increases with age, body mass index. Prevalence by ultrasound surveys:
      • By age 30, 30% of Native Americans
      • By age 60, 80% of Native Americans
      • By age 60, 30% of Caucasians
      • By age 60, 20% of African Americans
  • Predominant age: 5th and 6th decade
  • Predominant sex: Female > Male (2:1)
SIGNS AND SYMPTOMS
  • Asymptomatic. 5-10% become symptomatic each year.
  • Acute cholecystitis
    • Abdominal pain - sudden onset, intense, in epigastrium or right upper quadrant, radiates to shoulder or back. Pathognomonic feature is "biliary colic" a pain rising over 2-3 minutes to a plateau of intensity that is maintained for > 20 minutes.
    • Nausea and vomiting
    • Recurrent attacks following meals by 1-6 hours, lasting > 12 hours until recovered, usually < 3 days
    • Elevated temperature - mild to moderate
    • Local tenderness, rarely diffuse
    • Murphy's sign - inspiratory arrest elicited when palpating right upper quadrant while asking the patient for deep inhalation
    • Palpable gall bladder - 5% of cases
  • Common duct stone
    • Jaundice in 50%
    • Biliary colic 60%
    • Fever and chills 30%
    • Pruritus 10%
    • Loose bowel movements, light color
    • Mild to marked hepatomegaly > 80%
    • Tenderness infrequent
    • Palpable gall bladder 10%
    • Gallstone ileus (rare)
    • Gallstone > 3 cm fistulizes into bowel and obstructs at ileocecal area
    • Antecedent pain, often over weeks with non-biliary colic
    • Abdominal distension, mild tenderness
    • Air in biliary passages on plain x-ray
    • Intestinal obstruction at level of terminal ileum
  • Pancreatitis
    • Pain over upper abdomen
    • Nausea and vomiting
  • Empyema
    • Phlegmon of obstructed gall bladder
    • Insidious weight loss, mild wasting
    • Gradual onset of occult infection signs, fever, anorexia
    • Mass usually present
    • Tenderness usually absent
  • Chronic cholecystitis
    • Associated with gallstones, often asymptomatic; 20% become symptomatic over 15-20 years
    • Mild dyspepsia following fatty meals
CAUSES
  • Gallstones in 90-95% of cases. May obstruct the cystic duct, leading to acute cholecystitis; obstruction of the common bile duct, causing jaundice, or obstruction of the pancreatic duct, causing pancreatitis.
  • Gallbladder sludge, a viscous material, insoluble in bile, that layers on sonogram, and occasionally produces cholecystitis, common duct obstruction or pancreatitis. Occurs in most pregnant women, most total parenteral nutrition, and most patients with rapid weight loss
  • Acalculous cholecystitis in 5% of cases. Associated with severe stressful situations including cardiac surgery, multiple trauma. May be associated with ischemic damage to the gallbladder wall.
  • Bacteria. Usually do not initiate the inflammation but important in the complications of empyema and ascending cholangitis. In emphysematous cholecystitis, Clostridia are probably responsible for both initiation and complications.
  • Neoplasms and strictures of common bile duct. Usually associated with cholangitis and pancreatitis.
RISK FACTORS
  • Cardiac surgery
  • Trauma
  • Biliary parasites
  • Gallstones (see topic Cholelithiasis)
  • Rapid weight loss
  • Prolonged parenteral alimentation
  • Pregnancy

DIAGNOSIS

LABORATORY
  • Acute cholecystitis
    • Leukocytosis - 12,000-15,000
    • Liver tests usually abnormal; ALT, AST slightly elevated, alkaline phosphatase, GGT elevated with common duct obstruction
  • Common duct stone
    • High bilirubin in 50%, in 100% after 10 days
    • Elevated alkaline phosphatase and gamma glutamyl transpeptidase (GGT) in 85%
    • Positive blood culture in 15%
    • Barely abnormal ALT, AST
    • Elevated fasting bile salts
    • Elevated WBC if infection
    • Serum amylase may be elevated. If > 1000 units, concomitant pancreatitis should be considered.
Drugs that may alter lab results:
  • Steroids
  • Immunosuppressive drugs. These may mask leukocytosis and early signs of inflammation.
Disorders that may alter lab results:
  • Old age, malnutrition
  • Lymphoma, other immunocompromised states
PATHOLOGICAL FINDINGS
N/A
SPECIAL TESTS
99mTc Imino diacetic acid (HIDA) scan - highly sensitive (97%) for diagnosis of acute cholecystitis. HIDA derivatives are taken up by hepatocytes and excreted in bile and concentrated in gallbladder. Failure to see gallbladder in 1 hour is highly suspicious for acute cholecystitis. Usually abnormal in acalculous cholecystitis.
IMAGING
  • Plain radiographs (upright)
    • 20% of gallstones are radiopaque
    • Air cholangiogram if there is gallbladder-gut fistula
    • Emphysematous cholecystitis - air in the gallbladder wall or in lumen
  • Ultrasonography
    • Best technique to diagnose gallstones (high sensitivity - 95%, and specificity - 98%)
    • Best noninvasive imaging technique to diagnose acute cholecystitis. Findings include thick gall bladder wall (> 3 mm), gallbladder distension, sludge in lumen, pericholecystic fluid.
  • CT scan
    • No advantage over ultrasonography in gallstone/acute cholecystitis diagnosis
    • Better than ultrasonography to detect enlargement of pancreas. Helpful in the diagnosis of abscess formation. Shows thickened gall bladder wall in cancer.
    • Better than US for dilated common bile duct
DIAGNOSTIC PROCEDURES
  • Ultrasound or CT scan often diagnostic
  • Tc HIDA test during acute pain
  • Endoscopic retrograde cholangiopancreatography (ERCP) - to see status of biliary and pancreatic ducts
  • Percutaneous transhepatic cholangiography test (PTC) - gives more information about intrahepatic biliary system
  • Magnetic resonance almost as sensitive as ERCP to detect common bile duct stones. Endoscopic ultrasound is superior to ERCP in detecting common duct stones and has fewer complications.
  • Laparotomy - if unable to make diagnosis by less invasive means

TREATMENT

APPROPRIATE HEALTH CARE
  • Outpatient for patients with mild symptoms
  • Inpatient - patients with biliary colic lasting for more than 6 hours and showing toxicity, jaundice, rigors, or requiring narcotics for pain
  • Ascending cholangitis is a surgical emergency. If laparotomy is inappropriate, drainage can be obtained by ERCP or transhepatic cholangiography.
  • Direct drainage of gallbladder by invasive radiologist occasionally required
GENERAL MEASURES

NPO, IV fluids, nasogastric suction

SURGICAL MEASURES
  • Surgery (cholecystectomy) is the appropriate treatment for symptomatic cholecystitis. Best performed by laparoscopy, but a standard laparotomy is acceptable. Mortality rate - 0.1% in age <50 years and 0.8% age >50.
  • If there is jaundice, evaluation of the common bile duct is essential by intraoperative cholangiogram, or by a separate ERCP. Mortality rate for laparotomy is 0.1% < 50 years and 0.8% > 50 years. In acute cholecystitis - early cholecystectomy is the general practice rather than delayed interval cholecystectomy (delay only if surgery is contraindicated)
  • Laparoscopic cholecystostomy - rapidly replacing alternative surgical drainage procedure. If the patient is a poor risk, drainage of the gallbladder or biliary passages can be achieved by radiological or endoscopic techniques. This will allow control of infection and jaundice for several weeks or months.
  • Dissolution therapy - rarely used if laparoscopic cholecystectomy can be performed. Ursodeoxycholic acid (Actigall) in 10 mg/kg is the drug of choice. To be effective there must be a functioning gallbladder on oral cholecystography. Stones must be free of calcium. Few small stones have best prognosis to dissolve. An alternative drug is chenodeoxycholic acid (Chenodiol) 12-15 mg/kg/day.
  • Other indications for emergency surgery include - toxic patient, doubtful diagnosis, perforation or abscess
ACTIVITY

As tolerated by the patient

DIET
  • NPO during acute cholecystitis
  • Fatty meals precipitate mild attacks. Avoid if possible.
PATIENT EDUCATION

National Digestive Diseases Information Clearinghouse, Box NDDIC, Bethesda, MD 20892, (301) 468-6344

FOLLOW UP

PREVENTION/AVOIDANCE
  • Avoid risk factors when possible
  • During rapid weight loss following bariatric surgery or very low calorie diets, ursodeoxycholic acid (ursodiol)10 mg/kg/day
  • During total parenteral alimentation for more than one month, daily ingestion of 100 kcal, or injection of cholecystokinin
POSSIBLE COMPLICATIONS

Occur in about 5% cases of acute cholecystitis and include - perforation, abscess formation, fistula formation (intestine, colon, cutaneous), gangrene, empyema, cholangitis, hepatitis, pancreatitis, gallstone ileus, carcinoma

EXPECTED COURSE AND PROGNOSIS
  • In general the prognosis is good for gallbladder disease. Those who die during acute episodes are mainly due to other conditions, especially coronary artery disease.
  • Symptomatic gallstones usually have recurrent symptoms in 3 to 6 months indicating need for future action
  • After cholecystectomy, stones may recur in bile ducts

MISCELLANEOUS

ASSOCIATED CONDITIONS
  • Pancreatitis
  • Hemolytic anemias such as sickle cell disease, spherocytosis
  • Cirrhosis, hypersplenism
AGE-RELATED FACTORS

Pediatric: N/A
Geriatric: Sometimes difficult to diagnose; complications more likely; cholecystectomy mortality rate higher
Others: N/A

PREGNANCY

N/A

OTHER NOTES

Lithotripsy - can be used in patients with chronic cholecystitis. Contraindications - stones greater than 25 mm, more than 3 stones, calcified stones, bile duct stones, poor general condition. Largely replaced by laparoscopic cholecystectomy.

ABBREVIATIONS

N/A

Clinical Investigations

ROLE OF HOMOEOPATHY

Copyright © 2025 Selkey. All Rights Reserved.